The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

The HBCU Week Foundation, a non-profit organization dedicated to supporting Historically Black Colleges and Universities ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.

The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...

The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...

FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...

FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...